549 related articles for article (PubMed ID: 34040616)
1. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
Front Immunol; 2021; 12():682871. PubMed ID: 34040616
[TBL] [Abstract][Full Text] [Related]
2. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases.
Lee JW; Chun W; Lee HJ; Min JH; Kim SM; Seo JY; Ahn KS; Oh SR
Cells; 2021 Apr; 10(4):. PubMed ID: 33919784
[TBL] [Abstract][Full Text] [Related]
3. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
[TBL] [Abstract][Full Text] [Related]
5. Monocytes and macrophages in COVID-19: Friends and foes.
Meidaninikjeh S; Sabouni N; Marzouni HZ; Bengar S; Khalili A; Jafari R
Life Sci; 2021 Mar; 269():119010. PubMed ID: 33454368
[TBL] [Abstract][Full Text] [Related]
6. Distinctive features of severe SARS-CoV-2 pneumonia.
Budinger GRS; Misharin AV; Ridge KM; Singer BD; Wunderink RG
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34263736
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients.
Kloc M; Ghobrial RM; Lipińska-Opałka A; Wawrzyniak A; Zdanowski R; Kalicki B; Kubiak JZ
Cell Immunol; 2021 Feb; 360():104259. PubMed ID: 33359760
[TBL] [Abstract][Full Text] [Related]
8. Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2.
Roy RK; Sharma U; Wasson MK; Jain A; Hassan MI; Prakash H
Front Immunol; 2021; 12():763313. PubMed ID: 34659270
[No Abstract] [Full Text] [Related]
9. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
Carcaterra M; Caruso C
Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936
[TBL] [Abstract][Full Text] [Related]
10. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
11. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.
Margaroli C; Benson P; Sharma NS; Madison MC; Robison SW; Arora N; Ton K; Liang Y; Zhang L; Patel RP; Gaggar A
Cell Rep Med; 2021 Apr; 2(4):100242. PubMed ID: 33778787
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Wendisch D; Dietrich O; Mari T; von Stillfried S; Ibarra IL; Mittermaier M; Mache C; Chua RL; Knoll R; Timm S; Brumhard S; Krammer T; Zauber H; Hiller AL; Pascual-Reguant A; Mothes R; Bülow RD; Schulze J; Leipold AM; Djudjaj S; Erhard F; Geffers R; Pott F; Kazmierski J; Radke J; Pergantis P; Baßler K; Conrad C; Aschenbrenner AC; Sawitzki B; Landthaler M; Wyler E; Horst D; ; Hippenstiel S; Hocke A; Heppner FL; Uhrig A; Garcia C; Machleidt F; Herold S; Elezkurtaj S; Thibeault C; Witzenrath M; Cochain C; Suttorp N; Drosten C; Goffinet C; Kurth F; Schultze JL; Radbruch H; Ochs M; Eils R; Müller-Redetzky H; Hauser AE; Luecken MD; Theis FJ; Conrad C; Wolff T; Boor P; Selbach M; Saliba AE; Sander LE
Cell; 2021 Dec; 184(26):6243-6261.e27. PubMed ID: 34914922
[TBL] [Abstract][Full Text] [Related]
13. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
14. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.
Fang XZ; Wang YX; Xu JQ; He YJ; Peng ZK; Shang Y
Front Immunol; 2021; 12():651545. PubMed ID: 34149692
[TBL] [Abstract][Full Text] [Related]
15. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
16. Monocytes and Macrophages in COVID-19.
Knoll R; Schultze JL; Schulte-Schrepping J
Front Immunol; 2021; 12():720109. PubMed ID: 34367190
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
[TBL] [Abstract][Full Text] [Related]
18. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.
Xia B; Shen X; He Y; Pan X; Liu FL; Wang Y; Yang F; Fang S; Wu Y; Duan Z; Zuo X; Xie Z; Jiang X; Xu L; Chi H; Li S; Meng Q; Zhou H; Zhou Y; Cheng X; Xin X; Jin L; Zhang HL; Yu DD; Li MH; Feng XL; Chen J; Jiang H; Xiao G; Zheng YT; Zhang LK; Shen J; Li J; Gao Z
Cell Res; 2021 Aug; 31(8):847-860. PubMed ID: 34112954
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
